The ageing population in Malaysia combined with a rise in risk factors such as diabetes and hypertension has led to an increasing number of people requiring haemodialysis on an ongoing basis. Patients undergoing haemodialysis experience a heavier burden of cardiovascular disease (CVD) compared with the general population including a markedly increased risk of death.
This high cardiovascular mortality rate highlights the need to develop strategies for the identification and treatment of cardiovascular risk factors in order to improve the prognosis of this growing patient group.
Fresenius Medical Care is committed to supporting clinicians reduce their dialysis patients’ risks for cardiovascular morbidity and mortality by offering innovative products and services at every stage of haemodialysis therapy.
This includes supplying the most technologically advanced haemodialysis machines and consumables; offering complete dialysis care in our state-of-the-art dialysis centres; and installing and maintaining water treatment facilities for safe and effective dialysis.
The 5008 generation offers a highly pragmatic approach towards the provision of ONLINE haemodiafiltration (HDF) while maintaining an awareness of the limited resources available in dialysis units.
Dialysers and filters
Fresenius Medical Care offers a range of dialysers to meet the specific requirements of various therapies and individual patient needs.